Oxytocin

Oxytocin is a nine-amino-acid (nonapeptide) neuropeptide and hormone produced in the hypothalamus and released from the posterior pituitary. It has a characteristic cyclic structure formed by an internal disulfide bridge. Physiologically it is best known for stimulating uterine contractions during labor and milk ejection during breastfeeding, and it also acts within the brain as a neuromodulator implicated in social bonding, trust, stress regulation, and prosocial behavior. It is important to distinguish two very different contexts. Injectable oxytocin (e.g., Pitocin) is an FDA-approved medicine for specific obstetric indications such as labor induction and control of postpartum bleeding; this entry does not address that approved clinical use. The research-peptide context here is intranasal oxytocin, which has been studied as an experimental, off-label or investigational approach to influencing social cognition and to treating conditions such as autism spectrum disorder, social anxiety, and post-traumatic stress disorder (PTSD). In that context the evidence is decidedly mixed. Numerous randomized trials have tested intranasal oxytocin for social and psychiatric outcomes, but results have been inconsistent: some studies report modest benefits or specific effects (for example on certain PTSD-related responses), while several well-conducted trials, including larger studies in autism, found no substantial benefit on primary outcomes. Effects also appear to vary with dose frequency, individual genetics, sex, and context. Intranasal oxytocin for these uses is not an approved treatment. This entry summarizes the available science and community-reported practice for reference only; it is not medical advice.